
Consolidated cash and cash equivalents as of December 31, 2022, were $46 million.
Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $322.2 million for the fourth quarter of 2022, up 10% year-over-year. Net loss attributable to shareholders was $14.1 million, or $0.29 per share, compared to net income of $1.7 million, or $0.03 per share, last year. Adjusted EPS was $0.23. Consolidated cash and cash equivalents […]
“Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $322.2 million for the fourth quarter of 2022, up 10% year-over-year. Net loss attributable to shareholders was $14.1 million, or $0.29 per share, compared to net income of $1.7 million, or $0.03 per share, last year. Adjusted EPS was $0.23. Consolidated cash and cash equivalents […]
· March 7, 2023
Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $322.2 million for the fourth quarter of 2022, up 10% year-over-year.
Net loss attributable to shareholders was $14.1 million, or $0.29 per share, compared to net income of $1.7 million, or $0.03 per share, last year. Adjusted EPS was $0.23.

Consolidated cash and cash equivalents as of December 31, 2022, were $46 million.